Albemarle Stock Forecast, Price & News

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last twelve months. There are currently 3 sell ratings, 5 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Albemarle stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALB, but not buy additional shares or sell existing shares.
View analyst ratings for Albemarle or view top-rated stocks.

Wall Street analysts have given Albemarle a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Albemarle wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Albemarle saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 2,430,000 shares, a drop of 19.5% from the August 15th total of 3,020,000 shares. Based on an average trading volume of 1,210,000 shares, the short-interest ratio is presently 2.0 days. Currently, 2.1% of the shares of the company are short sold.
View Albemarle's Short Interest.

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, November 3rd 2021.
View our earnings forecast for Albemarle.

Albemarle Co. (NYSE:ALB) issued its quarterly earnings data on Tuesday, August, 3rd. The specialty chemicals company reported $0.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.06. The specialty chemicals company earned $773.90 million during the quarter, compared to analysts' expectations of $787.72 million. Albemarle had a net margin of 21.78% and a trailing twelve-month return on equity of 8.92%. Albemarle's revenue for the quarter was up 1.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.86 EPS.
View Albemarle's earnings history.

Albemarle's stock was trading at $70.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ALB shares have increased by 230.0% and is now trading at $231.25.
View which stocks have been most impacted by COVID-19.

Albemarle declared a quarterly dividend on Tuesday, July 20th. Investors of record on Friday, September 17th will be given a dividend of $0.39 per share on Friday, October 1st. This represents a $1.56 annualized dividend and a yield of 0.67%. The ex-dividend date is Thursday, September 16th.
View Albemarle's dividend history.

Albemarle pays an annual dividend of $1.56 per share and currently has a dividend yield of 0.67%. The dividend payout ratio of Albemarle is 37.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Albemarle will have a dividend payout ratio of 31.08% next year. This indicates that Albemarle will be able to sustain or increase its dividend.
View Albemarle's dividend history.

Albemarle issued an update on its FY 2021 earnings guidance on Friday, September, 10th. The company provided EPS guidance of $3.350-$3.700 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.620. The company issued revenue guidance of $3.20 billion-$3.30 billion, compared to the consensus revenue estimate of $3.23 billion.

19 equities research analysts have issued 12-month price targets for Albemarle's stock. Their forecasts range from $80.00 to $296.00. On average, they anticipate Albemarle's share price to reach $200.55 in the next twelve months. This suggests that the stock has a possible downside of 13.3%.
View analysts' price targets for Albemarle or view top-rated stocks among Wall Street analysts.

63 employees have rated Albemarle CEO Luther C. Kissam, IV on Glassdoor.com. Luther C. Kissam, IV has an approval rating of 75% among Albemarle's employees.

Some companies that are related to Albemarle include The Sherwin-Williams (SHW), Ecolab (ECL), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), Ashland Global (ASH), W. R. Grace & Co. (GRA), Balchem (BCPC), Quaker Chemical (KWR), Sensient Technologies (SXT), NewMarket (NEU), H.B. Fuller (FUL), Stepan (SCL), Minerals Technologies (MTX) and Valaris (VAL).
View all of ALB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), NVIDIA (NVDA), Rogers Communications (RCI) and Alibaba Group (BABA).

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.45%), BlackRock Inc. (8.34%), Franklin Resources Inc. (6.44%), State Street Corp (4.94%), Baillie Gifford & Co. (3.96%) and Primecap Management Co. CA (3.01%). Company insiders that own Albemarle stock include Eric Norris, John Clarence Barichivich III, Karen G Narwold, Karen G Narwold, Luther C Iv Kissam, Raphael Goszcz Crawford and Scott Tozier.
View institutional ownership trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Renaissance Technologies LLC, Avalon Investment & Advisory, Millennium Management LLC, Dimensional Fund Advisors LP, Royal Bank of Canada, Primecap Management Co. CA, and Aegon Asset Management UK PLC. Company insiders that have sold Albemarle company stock in the last year include Eric Norris, John Clarence Barichivich III, Karen G Narwold, Luther C Iv Kissam, Raphael Goszcz Crawford, and Scott Tozier.
View insider buying and selling activity for Albemarle or view top insider-selling stocks.

ALB stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., FMR LLC, Bank of New York Mellon Corp, State Street Corp, Amundi, Franklin Resources Inc., Twin Tree Management LP, and AGF Investments Inc..
View insider buying and selling activity for Albemarle or or view top insider-buying stocks.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALB stock can currently be purchased for approximately $231.25.

Albemarle has a market capitalization of $27.04 billion and generates $3.13 billion in revenue each year. The specialty chemicals company earns $375.76 million in net income (profit) each year or $4.12 on an earnings per share basis.

Albemarle employs 5,900 workers across the globe.

The following companies are subsidiares of Albemarle: ACI Cyprus L.L.C., Albemarle (Thailand) Co. Ltd., Albemarle Argentina SRL, Albemarle Brazil Holdings LTDA., Albemarle Care Fund, Albemarle Catalysts Company B.V., Albemarle Chemical Canada Ltd., Albemarle Chemicals (Shanghai) Company Limited, Albemarle Chemicals Ltd., Albemarle Chemicals Private Limited, Albemarle Chemicals S.A.S., Albemarle Chemicals South Africa (PTY) Ltd., Albemarle Delaware Holdings 1 LLC, Albemarle Delaware Holdings 2 LLC, Albemarle Dutch Holdings 2 B.V., Albemarle Dutch Holdings B.V., Albemarle Europe Sprl, Albemarle Finance Company B.V., Albemarle Foundation, Albemarle Germany Gmbh, Albemarle Hilfe GmbH Unterstutzungskasse, Albemarle Holdings Company Limited, Albemarle Holdings Limited, Albemarle Hungary Ltd., Albemarle Italy S.R.L., Albemarle Japan Corporation, Albemarle Japan Holdings B.V., Albemarle Knight Lux 1 Holdings Corporation, Albemarle Korea Corporation, Albemarle Limitada, Albemarle Lithium Holding Corporation, Albemarle Lithium Holding GmbH, Albemarle Lithium Pty Ltd, Albemarle Malaysia Sdn Bhd, Albemarle Management (Shanghai) Co. Ltd., Albemarle Middle East Corporation FZE, Albemarle Netherlands B.V., Albemarle New Holding GmbH, Albemarle Overseas Employment Corporation, Albemarle Quimica LTDA, Albemarle Saudi Trading Company, Albemarle Singapore PTE LTD, Albemarle Spain S.L., Albemarle Taiwan Limited, Albemarle U.S. Inc., Albemarle Vietnam Limited Liability Company, Albemarle Wodgina Pty Ltd, Albemarle de Venezuela C.A., Dynamit Nobel GmbH, Dynamit Nobel Unterstützungsfonds GmbH, Excalibur II Realty Company, Excalibur Realty Company, Foote Chile Holding Company, Foote Minera e Inversiones Ltda., Jiangxi Albemarle Lithium Co. Ltd., Jordan Bromine Company Limited, Knight Lux 1 S.à r.l., Knight Lux 2 S.à r.l., MARBL Lithium Operations Pty Ltd, Metalon Environmental Management & Solutions GmbH, PT Albemarle Chemicals Indonesia, RSG Immobilien GmbH, RT Lithium Limited, Rockwood Holdings, Rockwood Holdings Inc., Rockwood Lithium India Pvt. Ltd., Rockwood Lithium Japan K.K., Rockwood Lithium Korea LLC, Rockwood Lithium Shanghai Co. Ltd., Rockwood Lithium Taiwan Co. Ltd., Rockwood Specialties GmbH, Rockwood Specialties Group LLC, Rockwood Specialties LLC, Rockwood Specialties Limited, Sales de Magnesio Limitada, Shandong Sinobrom Albemarle Bromine Chemicals Company Limited, and Sichuan Guorun New Material Co. Ltd..

Albemarle was founded in 1994.

The official website for Albemarle is www.albemarle.com.

Albemarle is headquartered at 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at (980) 299-5700 or via email at [email protected]